Physician profile
Meagan Rieff
NPI 1114641362
$647.42
in general payments reported to CMS, 2019-2025
8 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $124 · 2024: $247 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $323.21 | 2023-2025 | Avvigo Guidance System, Opticross, General - Therapies |
| Terumo Medical Corporation | $123.39 | 2023-2025 | Azur Cx Detachable, Angio-Seal, Glidewire |
| Kestra Medical Technology Services, INC. | $62.73 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.05 | 2025 | Lifevest |
| Astellas Pharma US INC | $29.60 | 2024 | Veozah |
| Coopersurgical, INC. | $23.54 | 2025 | Paragard T 380a |
| Exeltis, USA INC. | $19.65 | 2023 | Slynd |
| Organon LLC | $7.25 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Rieff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.